Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

Human Molecular Genetics

Volumn 10, Issue 12, 2001, Pages 1265-1273

  Sarmanová, Jana ^a   Benesová, Katerina ^b   Gut, Ivan ^a   Nedelcheva Kristensen, Vessela ^c   Tynková, Lucie ^a   Soucek, Pavel ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE;

ADULT; AGE; ARTICLE; ASSAY; BIOTRANSFORMATION; CANCER GRADING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME METABOLISM; EXON; FEMALE; GENDER; GENE DELETION; GENOTYPE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0035363947     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.12.1265     Document Type: Article

References (52)

1. Human cytochrome P450 enzymes
2. Diagnosis of polymorphism in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review
3. Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P450 1A1 gene
4. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose
5. Association of cigarette smoking and CYP1A1 polymorphism with adenocarcinoma of the lung by grades of differentiation
6. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphism in a Japanese population
7. CYP1A1 Genetic polymorphism and in situ colorectal cancer
8. Human CYP1A1 (cytochrome P 450) gene: Lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population
9. Point mutation MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population
10. Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence
11. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: Studies in upper aerodigestive tract cancers
12. A CYP1A1 restriction fragment length polymorphism is associated with cancer in African-American women
13. Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects
14. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene
15. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer
16. Combined genetic polymorphism and risk for development of lung cancer
17. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer in relation to p53 gene mutation
18. Association between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer
19. Cytochrome P4502E1 genetic polymorphism and risk of nasopharyngeal carcinoma: Results from a case-control study conducted in Taiwan
20. Mammalian epoxide hydrases: Inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds
21. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
22. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
23. Association between lung cancer and microsomal epoxide hydrolase genotypes
24. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer
25. Genetic metabolic polymorphisms and the risk of cancer, a review of the literature
26. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
27. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
28. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
29. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome band 11q13 and 12q13-14
30. Naturally occuring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties
31. Association between glutathione S-transferase π genetic polymorphisms and oral cancer risk
32. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk
33. A case-control study of non-Hodgkin's lymphoma and exposure to pesticides
34. Some risk factors for non-Hodgkin's lymphoma
35. Benzene and non-Hodgkin's lymphoma
36. Metabolic polymorphisms and susceptibility to cancer
37. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias
38. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms
39. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
40. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer
41. Association between lung cancer and microsomal epoxide hydrolase genotypes
42. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers
43. Polycyclic hydrocarbon activation: Bay regions and beyond
44. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7, 12-dimethyl-benz[a]anthracene
45. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene diolepoxide
46. Association between glutathione S-transferase π genetic polymorphisms and oral cancer risk
47. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
48. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer
49. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: Relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
50. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: A case-control study
51. Hodgkin's disease
52. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls